Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

HAEMOPHILUS INFLUENZAE TYPE B: 14 Adverse Event Reports & Safety Profile

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
14
Total FAERS Reports
3 (21.4%)
Deaths Reported
5
Hospitalizations
14
As Primary/Secondary Suspect
3
Life-Threatening

First Report: 20120221 · Latest Report: 20250106

What Are the Most Common HAEMOPHILUS INFLUENZAE TYPE B Side Effects?

#1 Most Reported
Vomiting
3 reports (21.4%)
#2 Most Reported
Vaccination failure
2 reports (14.3%)
#3 Most Reported
Stridor
2 reports (14.3%)

All HAEMOPHILUS INFLUENZAE TYPE B Side Effects by Frequency

No side effect data available.

Who Reports HAEMOPHILUS INFLUENZAE TYPE B Side Effects? Age & Gender Data

Gender: 57.1% female, 42.9% male. Average age: 20.2 years. Most reports from: US. View detailed demographics →

Is HAEMOPHILUS INFLUENZAE TYPE B Getting Safer? Reports by Year

YearReportsDeathsHosp.
2012 1 0 0
2016 3 1 0
2017 2 0 1
2022 1 0 0
2025 1 0 0

View full timeline →

What Is HAEMOPHILUS INFLUENZAE TYPE B Used For?

IndicationReports
Prophylaxis 7

Official FDA Label for HAEMOPHILUS INFLUENZAE TYPE B

Official prescribing information from the FDA-approved drug label.